In summary, in this study, we demonstrate that fedratinib suppresses proliferation, migration, and apoptosis resistance in esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 signaling pathway. This evidence concerns the gene STAT3 and esophageal squamous cell carcinoma.